These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32646634)

  • 1. Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
    Krell-Roesch J; Syrjanen JA; Vassilaki M; Lowe VJ; Vemuri P; Mielke MM; Machulda MM; Stokin GB; Christianson TJ; Kremers WK; Jack CR; Knopman DS; Petersen RC; Geda YE
    Am J Geriatr Psychiatry; 2021 Feb; 29(2):179-191. PubMed ID: 32646634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
    Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
    Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.
    Krell-Roesch J; Ruider H; Lowe VJ; Stokin GB; Pink A; Roberts RO; Mielke MM; Knopman DS; Christianson TJ; Machulda MM; Jack CR; Petersen RC; Geda YE
    J Alzheimers Dis; 2016 Jul; 53(4):1609-16. PubMed ID: 27447426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
    Frings L; Hellwig S; Bormann T; Spehl TS; Buchert R; Meyer PT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1442-1448. PubMed ID: 29546632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study.
    Tondo G; Boccalini C; Caminiti SP; Presotto L; Filippi M; Magnani G; Frisoni GB; Iannaccone S; Perani D
    J Alzheimers Dis; 2021; 80(1):433-445. PubMed ID: 33579848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment.
    Pink A; Krell-Roesch J; Syrjanen JA; Vassilaki M; Lowe VJ; Vemuri P; Stokin GB; Christianson TJ; Kremers WK; Jack CR; Knopman DS; Petersen RC; Geda YE
    Alzheimers Dement; 2022 Oct; 18(10):1824-1831. PubMed ID: 34877794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
    Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
    J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
    Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
    Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
    Shokouhi S; Claassen D; Kang H; Ding Z; Rogers B; Mishra A; Riddle WR;
    J Nucl Med; 2013 Sep; 54(9):1564-9. PubMed ID: 23864720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
    Baran TM; Lin FV;
    J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
    Tondo G; Boccalini C; Vanoli EG; Presotto L; Muscio C; Ciullo V; Banaj N; Piras F; Filippini G; Tiraboschi P; Tagliavini F; Frisoni GB; Cappa SF; Spalletta G; Perani D;
    Neurology; 2022 Jul; 99(3):e258-e269. PubMed ID: 35487700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Gatchel JR; Donovan NJ; Locascio JJ; Becker JA; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Am J Geriatr Psychiatry; 2017 Jul; 25(7):683-693. PubMed ID: 28410856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
    Delrieu J; Desmidt T; Camus V; Sourdet S; Boutoleau-Bretonnière C; Mullin E; Vellas B; Payoux P; Lebouvier T;
    Int J Geriatr Psychiatry; 2015 May; 30(5):470-7. PubMed ID: 24953008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.